Multiple system atrophy Clinical Trials
Recruiting multiple system atrophy studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat multiple system atrophy. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting multiple system atrophy studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting multiple system atrophy trials
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
Expansion Study of ALT001 in Patients With Multiple System Atrophy
Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy
Prospective Multicenter Registry Study of Multiple System Atrophy in China
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
The CurePSP Genetics Program
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System
PET Imaging Evaluation of [11C]SY08
The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Medical Decision Making in Multiple System Atrophy
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
NYSCF Scientific Discovery Biobank
Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
North American Prodromal Synucleinopathy Consortium Stage 2
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
CPAP for the Treatment of Supine Hypertension
Synaptic Loss in Multiple System Atrophy
Comprehensive Swallowing Rehabilitation in Patients With MSA
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
Insulin Resistance in Multiple System Atrophy
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
North American Prodromal Synucleinopathy Consortium
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
The Swedish BioFINDER 2 Study
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Natural History Study of Synucleinopathies
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Cerebro Spinal Fluid Collection (CSF)
Multiple system atrophy clinical trials — common questions
Are multiple system atrophy clinical trials free to join?
Yes. Participating in a multiple system atrophy clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a multiple system atrophy clinical trial?
Each multiple system atrophy study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a multiple system atrophy trial near me?
Use the location controls above. We'll show recruiting multiple system atrophy trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many multiple system atrophy trials are recruiting right now?
We're currently tracking roughly 22 recruiting multiple system atrophy trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.